TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ATYR

aTyr Pharma, Inc.

Healthcare · Biotechnology

0.2553$ -8.3% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

aTyr Pharma, Inc. (ATYR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 70 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATYR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
86 81 66 61 94 89 78 68 60 53 50 49 44 36 54 48 42 39 55 49 124 116 105 96 96 96 137 133 125 121 113 106 92 97 97 102 107 94 80 70
74 75 64 59 92 87 76 66 58 51 45 44 39 32 50 44 38 36 52 46 122 114 103 93 85 81 119 114 107 103 97 90 76 82 83 87 93 80 68 58
34 38 29 36 30 21 22 19 32 23 13 15 17 9.2 39 22 18 17 13 2.2 60 2.3 8.3 8.5 18 10.0 21 12 9.8 23 6.8 6.8 11 11 10 17 6.2 11 10 16
71 72 62 57 90 85 74 64 56 50 43 42 38 31 50 41 36 32 51 44 116 108 99 89 77 66 114 109 102 98 84 78 66 72 76 80 90 79 67 57
– – – – – – – – – – 0.6 – – 0.1 – 0.8 0.2 2.0 0.1 0.1 0.1 0.4 0.4 0.4 0.9 12 1.6 1.3 2.1 2.4 2.5 1.6 1.8 1.7 1.0 0.5 1.0 0.9 0.5 0.4
12 18 15 21 22 25 24 23 21 19 20 19 17 15 12 12 9.6 7.2 5.6 8.2 6.5 6.4 6.4 9.6 19 25 27 27 27 30 29 25 26 27 22 27 27 27 22 21
12 8.5 6.5 9.6 9.7 10 11 11 11 11 11 11 12 13 10 9.8 8.0 5.9 4.5 7.3 5.8 6.0 6.3 9.3 11 14 14 12 13 16 16 12 14 15 11 16 16 15 12 11
2.6 0.3 1.1 2.8 2.3 5.0 7.0 7.7 7.7 7.8 8.5 8.5 8.6 9.5 7.6 5.8 3.9 0.9 0.9 0.9 0.9 1.0 1.0 1.0 0.8 0.9 0.8 1.1 1.2 1.3 1.1 1.2 1.2 1.3 1.3 1.3 1.4 1.5 1.5 1.5
3.6 2.6 1.2 2.7 3.6 2.3 1.5 0.8 0.6 1.0 0.8 0.7 1.3 0.8 0.7 0.6 1.4 1.4 1.2 2.2 0.9 1.0 1.6 1.7 3.1 3.1 4.0 0.5 2.0 3.5 4.9 1.3 3.9 4.3 1.5 3.9 4.1 3.9 2.8 3.2
74 63 51 40 72 64 54 45 39 34 29 30 27 21 42 36 32 32 50 41 118 109 99 87 77 71 110 106 98 91 84 82 65 70 75 75 80 67 58 49
-203 -216 -229 -242 -253 -264 -275 -285 -292 -299 -305 -311 -316 -322 -321 -327 -334 -339 -346 -356 -364 -372 -384 -397 -410 -418 -430 -442 -453 -468 -484 -500 -517 -532 -547 -566 -592 -606 -617 -627
1.7 1.7 1.7 1.7 1.8 2.1 2.1 2.1 2.1 2.2 2.4 3.2 3.8 3.9 6.9 9.4 9.6 11 14 16 18 28 28 28 29 29 42 55 58 59 66 72 76 83 86 90 97 98 98 98

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?